Literature DB >> 26346640

Intranasal Oxytocin Affects Amygdala Functional Connectivity after Trauma Script-Driven Imagery in Distressed Recently Trauma-Exposed Individuals.

Jessie L Frijling1,2, Mirjam van Zuiden1, Saskia B J Koch1,2, Laura Nawijn1,2, Dick J Veltman3, Miranda Olff1,4.   

Abstract

Approximately 10% of trauma-exposed individuals go on to develop post-traumatic stress disorder (PTSD). Neural emotion regulation may be etiologically involved in PTSD development. Oxytocin administration early post-trauma may be a promising avenue for PTSD prevention, as intranasal oxytocin has previously been found to affect emotion regulation networks in healthy individuals and psychiatric patients. In a randomized double-blind placebo-controlled between-subjects functional magnetic resonance (fMRI) study, we assessed the effects of a single intranasal oxytocin administration (40 IU) on seed-based amygdala resting-state FC with emotion regulation areas (ventromedial prefrontal cortex (vmPFC), ventrolateral prefrontal cortex (vlPFC)), and salience processing areas (insula, dorsal anterior cingulate cortex (dACC)) in 37 individuals within 11 days post trauma. Two resting-state scans were acquired; one after neutral- and one after trauma-script-driven imagery. We found that oxytocin administration reduced amygdala-left vlPFC FC after trauma script-driven imagery, compared with neutral script-driven imagery, whereas in PL-treated participants enhanced amygdala-left vlPFC FC was observed following trauma script-driven imagery. Irrespective of script condition, oxytocin increased amygdala-insula FC and decreased amygdala-vmPFC FC. These neural effects were accompanied by lower levels of sleepiness and higher flashback intensity in the oxytocin group after the trauma script. Together, our findings show that oxytocin administration may impede emotion regulation network functioning in response to trauma reminders in recently trauma-exposed individuals. Therefore, caution may be warranted in administering oxytocin to prevent PTSD in distressed, recently trauma-exposed individuals.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26346640      PMCID: PMC4793112          DOI: 10.1038/npp.2015.278

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  70 in total

1.  Evoked axonal oxytocin release in the central amygdala attenuates fear response.

Authors:  H Sophie Knobloch; Alexandre Charlet; Lena C Hoffmann; Marina Eliava; Sergey Khrulev; Ali H Cetin; Pavel Osten; Martin K Schwarz; Peter H Seeburg; Ron Stoop; Valery Grinevich
Journal:  Neuron       Date:  2012-02-09       Impact factor: 17.173

2.  Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquisition and extinction.

Authors:  Nisrine Lahoud; Mouna Maroun
Journal:  Psychoneuroendocrinology       Date:  2013-10       Impact factor: 4.905

3.  No laughing matter: intranasal oxytocin administration changes functional brain connectivity during exposure to infant laughter.

Authors:  Madelon M E Riem; Marinus H van IJzendoorn; Mattie Tops; Maarten A S Boksem; Serge A R B Rombouts; Marian J Bakermans-Kranenburg
Journal:  Neuropsychopharmacology       Date:  2011-12-21       Impact factor: 7.853

Review 4.  Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder.

Authors:  Amy L Mahan; Kerry J Ressler
Journal:  Trends Neurosci       Date:  2011-07-26       Impact factor: 13.837

5.  Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex.

Authors:  Ipe Ninan
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

6.  Oxytocin modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized controlled trial.

Authors:  Madelon M E Riem; Marian J Bakermans-Kranenburg; Suzanne Pieper; Mattie Tops; Maarten A S Boksem; Robert R J M Vermeiren; Marinus H van Ijzendoorn; Serge A R B Rombouts
Journal:  Biol Psychiatry       Date:  2011-04-05       Impact factor: 13.382

Review 7.  Oxytocin's role in anxiety: a critical appraisal.

Authors:  Kai MacDonald; David Feifel
Journal:  Brain Res       Date:  2014-01-24       Impact factor: 3.252

8.  Acute stress disorder versus chronic posttraumatic stress disorder: inhibition of fear as a function of time since trauma.

Authors:  Tanja Jovanovic; Andrea Jambrošić Sakoman; Dragica Kozarić-Kovačić; Ana Havelka Meštrović; Erica J Duncan; Michael Davis; Seth D Norrholm
Journal:  Depress Anxiety       Date:  2012-08-20       Impact factor: 6.505

9.  Neural correlates of reexperiencing, avoidance, and dissociation in PTSD: symptom dimensions and emotion dysregulation in responses to script-driven trauma imagery.

Authors:  James W Hopper; Paul A Frewen; Bessel A van der Kolk; Ruth A Lanius
Journal:  J Trauma Stress       Date:  2007-10

10.  Amygdala response to negative stimuli predicts PTSD symptom onset following a terrorist attack.

Authors:  Katie A McLaughlin; Daniel S Busso; Andrea Duys; Jennifer Greif Green; Sonia Alves; Marcus Way; Margaret A Sheridan
Journal:  Depress Anxiety       Date:  2014-07-03       Impact factor: 6.505

View more
  22 in total

Review 1.  Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry.

Authors:  Najmeh Khalili-Mahani; Serge A R B Rombouts; Matthias J P van Osch; Eugene P Duff; Felix Carbonell; Lisa D Nickerson; Lino Becerra; Albert Dahan; Alan C Evans; Jean-Paul Soucy; Richard Wise; Alex P Zijdenbos; Joop M van Gerven
Journal:  Hum Brain Mapp       Date:  2017-02-01       Impact factor: 5.038

Review 2.  A Public Health Perspective of Post-Traumatic Stress Disorder.

Authors:  Ghazi I Al Jowf; Ziyad T Ahmed; Ning An; Rick A Reijnders; Elena Ambrosino; Bart P F Rutten; Laurence de Nijs; Lars M T Eijssen
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

Review 3.  Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD).

Authors:  Federico Bertolini; Lindsay Robertson; Jonathan I Bisson; Nicholas Meader; Rachel Churchill; Giovanni Ostuzzi; Dan J Stein; Taryn Williams; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2022-02-10

Review 4.  Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience.

Authors:  Zachary V Johnson; Larry J Young
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

5.  Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder.

Authors:  Julianne C Flanagan; Anne Hand; Amber M Jarnecke; Megan M Moran-Santa Maria; Kathleen T Brady; Jane E Joseph
Journal:  Exp Clin Psychopharmacol       Date:  2018-08       Impact factor: 3.157

6.  Effects of oxytocin on methamphetamine-seeking exacerbated by predator odor pre-exposure in rats.

Authors:  Chantelle L Ferland; Carmela M Reichel; Jacqueline F McGinty
Journal:  Psychopharmacology (Berl)       Date:  2015-12-23       Impact factor: 4.530

7.  Oxytocin and Stress-related Disorders: Neurobiological Mechanisms and Treatment Opportunities.

Authors:  Lauren M Sippel; Casey E Allington; Robert H Pietrzak; Ilan Harpaz-Rotem; Linda C Mayes; Miranda Olff
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-02-17

8.  Variation in the oxytocin receptor gene (OXTR) is associated with differences in moral judgment.

Authors:  Regan M Bernhard; Jonathan Chaponis; Richie Siburian; Patience Gallagher; Katherine Ransohoff; Daniel Wikler; Roy H Perlis; Joshua D Greene
Journal:  Soc Cogn Affect Neurosci       Date:  2016-08-06       Impact factor: 3.436

9.  Canine companionship is associated with modification of attentional bias in posttraumatic stress disorder.

Authors:  Steven H Woodward; Andrea L Jamison; Sasha Gala; Tyson H Holmes
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

10.  Decreased Plasma Oxytocin Levels in Patients With PTSD.

Authors:  Claudia Carmassi; Donatella Marazziti; Federico Mucci; Alessandra Della Vecchia; Filippo Maria Barberi; Stefano Baroni; Gino Giannaccini; Lionella Palego; Gabriele Massimetti; Liliana Dell'Osso
Journal:  Front Psychol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.